Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine and Quetiapine for Postoperative Sleep After TKA
NCT04728581Not yet recruiting
- Sponsor
- St. Anna Ziekenhuis
- Start
- Jan 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Insomnia comparing Low dose Mirtazapine, Low dose Quetiapine and Placebo (3 arms). Primary endpoint: Oxford Knee Score at 6 weeks. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
mirtazapinequetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04728581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728581.